RU2018121813A - Предварительно заполненный пластиковый шприц, содержащий антагонист vegf - Google Patents
Предварительно заполненный пластиковый шприц, содержащий антагонист vegf Download PDFInfo
- Publication number
- RU2018121813A RU2018121813A RU2018121813A RU2018121813A RU2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A
- Authority
- RU
- Russia
- Prior art keywords
- filled syringe
- preceding paragraphs
- syringe according
- vegf antagonist
- liquid preparation
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title claims 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title claims 5
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title claims 5
- 229940071643 prefilled syringe Drugs 0.000 claims 15
- 239000007788 liquid Substances 0.000 claims 6
- 238000002360 preparation method Methods 0.000 claims 6
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims 4
- 201000011190 diabetic macular edema Diseases 0.000 claims 4
- 206010047571 Visual impairment Diseases 0.000 claims 3
- 208000029257 vision disease Diseases 0.000 claims 3
- 230000004393 visual impairment Effects 0.000 claims 3
- 206010060823 Choroidal neovascularisation Diseases 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 229920001296 polysiloxane Polymers 0.000 claims 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 108091008605 VEGF receptors Proteins 0.000 claims 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims 1
- 229960002833 aflibercept Drugs 0.000 claims 1
- 108010081667 aflibercept Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 208000001309 degenerative myopia Diseases 0.000 claims 1
- 230000004340 degenerative myopia Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 229960003876 ranibizumab Drugs 0.000 claims 1
- 210000001957 retinal vein Anatomy 0.000 claims 1
- 239000000565 sealant Substances 0.000 claims 1
- 239000004447 silicone coating Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3286—Needle tip design, e.g. for improved penetration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Claims (16)
1. Предварительно заполненный шприц, содержащий жидкий препарат антагониста VEGF и имеющий корпус, выполненный из пластика, свободный от силикона и, кроме того, имеющий несъемный уплотнитель.
2. Предварительно заполненный шприц, содержащий жидкий препарат антагониста VEGF и имеющий корпус, выполненный из пластика, свободный от силикона и имеющий длину от 45 мм до 65 мм.
3. Предварительно заполненный шприц по п. 1 или 2, отличающийся тем, что антагонист VEGF представляет собой анти-VEGF антитело или антигенсвязывающий фрагмент такого антитела, или слитый белок рецептора VEGF.
4. Предварительно заполненный шприц по п. 3, отличающийся тем, что анти-VEGF антагонист представляет собой ранибизумаб или афлиберцепт.
5. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что концентрация антагониста составляет 1-100 мг/мл.
6. Предварительно заполненный шприц по любому из предшествующих пунктов, содержащий менее 50 частиц, имеющих диаметр 10 мкм или более, на мл жидкого препарата.
7. Предварительно заполненный шприц по любому из предшествующих пунктов, содержащий менее 5 частиц, имеющих диаметр 25 мкм или более, на мл жидкого препарата.
8. Предварительно заполненный шприц по любому из предшествующих пунктов, характеризующийся силой трения скольжения, меньшей или равной 10 Н.
9. Предварительно заполненный шприц по любому из предшествующих пунктов, дополнительно имеющий свободный от силикона уплотнитель.
10. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что корпус шприца выполнен из циклоолефинового полимера или циклоолефинового сополимера.
11. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что корпус шприца имеет внутреннее покрытие, отличное от силиконового покрытия.
12. Предварительно заполненный шприц по любому из предшествующих пунктов, имеющий несъемную иглу.
13. Набор, включающий один или более предварительно заполненных шприцев по любому из предшествующих пунктов.
14. Предварительно заполненный шприц по любому из пп. 1-11 для применения в введении жидкого препарата антагониста VEGF пациенту, имеющему заболевание глаз.
15. Предварительно заполненный шприц для применения по п. 13 в случае, когда заболевание глаз выбирают из группы, состоящей из возрастной дегенерации желтого пятна (AMD), нарушения зрения вследствие диабетического отека желтого пятна (DME), нарушения зрения вследствие вторичного диабетического отека желтого пятна при окклюзии вен сетчатки (окклюзии ветвей центральной ВС или окклюзии центральной ВС), диабетической ретинопатии у пациентов с диабетическим отеком желтого пятна или нарушения зрения вследствие вторичной хориоидальной неоваскуляризации (CNV) при патологической миопии.
16. Предварительно заполненный шприц для применения по п. 14 или 15, при этом пациенту вводят жидкий препарат в объеме 30-100 мкл.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15195177.9 | 2015-11-18 | ||
| EP15195177 | 2015-11-18 | ||
| PCT/EP2016/078136 WO2017085253A1 (en) | 2015-11-18 | 2016-11-18 | Pre-filled plastic syringe containing a vegf antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018121813A true RU2018121813A (ru) | 2019-12-19 |
| RU2018121813A3 RU2018121813A3 (ru) | 2020-03-05 |
Family
ID=54608352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018121813A RU2018121813A (ru) | 2015-11-18 | 2016-11-18 | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20180326126A1 (ru) |
| EP (1) | EP3377151A1 (ru) |
| JP (2) | JP2019501687A (ru) |
| KR (1) | KR20180083377A (ru) |
| CN (1) | CN108290004A (ru) |
| AU (1) | AU2016356047B2 (ru) |
| BR (1) | BR112018010005A2 (ru) |
| CA (1) | CA3005692A1 (ru) |
| MX (1) | MX2018006171A (ru) |
| RU (1) | RU2018121813A (ru) |
| WO (1) | WO2017085253A1 (ru) |
| ZA (1) | ZA201802922B (ru) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| CN108712911A (zh) | 2015-12-30 | 2018-10-26 | 科达制药股份有限公司 | 抗体及其缀合物 |
| AU2017213103B2 (en) | 2016-01-26 | 2022-08-11 | Formycon Ag | Liquid formulation of a VEGF antagonist |
| ES2965405T3 (es) | 2017-12-13 | 2024-04-15 | Regeneron Pharma | Dispositivos y procedimientos para administración de dosis de precisión |
| US20200390596A1 (en) | 2018-01-03 | 2020-12-17 | Irenix Medical, Inc. | Therapeutic Agent Delivery Devices Having Integrated Pain Mitigation, and Methods for Using the Same |
| EP4495136A3 (en) | 2018-01-26 | 2025-04-23 | The Regents of the University of California | Methods and compositions for treatment of angiogenic disorders using anti-vegf agents |
| WO2019169341A1 (en) | 2018-03-02 | 2019-09-06 | Kodiak Sciences Inc. | Il-6 antibodies and fusion constructs and conjugates thereof |
| IL318714A (en) | 2018-05-10 | 2025-03-01 | Regeneron Pharma | Formulations that include high concentrations of VEGF receptor fusion protein |
| SG11202103064YA (en) | 2018-10-29 | 2021-05-28 | Hoffmann La Roche | Antibody formulation |
| PT3659594T (pt) * | 2018-11-30 | 2020-12-28 | Stegemann Klaus | Uma solução estéril com uma seringa de aplicação que contém um agente ativo médico e processo para a sua disponibilização |
| BR112021024137A2 (pt) | 2019-06-05 | 2022-02-08 | Regeneron Pharma | Dispositivos e métodos para entrega de dose com precisão |
| US12059555B2 (en) | 2019-09-03 | 2024-08-13 | Amgen Inc. | Injection device for drug delivery and packaging for the injection device |
| WO2021056020A1 (en) | 2019-09-16 | 2021-03-25 | Amgen Inc. | Method for external sterilization of drug delivery device |
| US11912784B2 (en) | 2019-10-10 | 2024-02-27 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| CN114867487A (zh) | 2019-11-25 | 2022-08-05 | 加利福尼亚大学董事会 | 用于眼内新生血管的长效vegf抑制剂 |
| EP3906249A1 (en) * | 2019-12-06 | 2021-11-10 | Regeneron Pharmacetucals, Inc. | Anti-vegf protein compositions and methods for producing the same |
| KR20230008830A (ko) | 2020-05-08 | 2023-01-16 | 리제너론 파마슈티칼스 인코포레이티드 | Vegf 트랩 및 미니-트랩 및 안구 장애 및 암의 치료 방법 |
| CN116322582A (zh) * | 2020-08-12 | 2023-06-23 | 里珍纳龙药品有限公司 | 用于向眼部组织输送药物的系统和方法 |
| EP4217025A4 (en) * | 2020-09-25 | 2024-11-13 | Ocuject, LLC | SYRINGE INJECTOR WITH FEEDBACK MECHANISM |
| KR102720956B1 (ko) * | 2020-12-15 | 2024-10-24 | 삼천당제약주식회사 | 안과용 제형을 포함하는 시린지 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3380450A (en) * | 1965-05-10 | 1968-04-30 | William H. Adelberger | Sterile disposable plastic prefilled syringe |
| US5731424A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
| US5731144A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands |
| US6124449A (en) | 1990-06-11 | 2000-09-26 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
| US6582959B2 (en) | 1991-03-29 | 2003-06-24 | Genentech, Inc. | Antibodies to vascular endothelial cell growth factor |
| DK1975181T3 (da) | 1992-10-28 | 2011-06-06 | Genentech Inc | Anvendelse af vaskulære endothelcelle-vækstfaktor-antagonister |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| CA2221318C (en) | 1995-06-02 | 2012-01-24 | Nexstar Pharmaceuticals, Inc. | High affinity oligonucleotide ligands to growth factors |
| JP3957765B2 (ja) | 1997-04-07 | 2007-08-15 | ジェネンテク・インコーポレイテッド | 抗ｖｅｇｆ抗体 |
| US20020032315A1 (en) | 1997-08-06 | 2002-03-14 | Manuel Baca | Anti-vegf antibodies |
| ATE501170T1 (de) | 1997-04-07 | 2011-03-15 | Genentech Inc | Verfahren zur herstellung humanisierter antikörper durch randomisierte mutagenese |
| US6703020B1 (en) | 1999-04-28 | 2004-03-09 | Board Of Regents, The University Of Texas System | Antibody conjugate methods for selectively inhibiting VEGF |
| IL146890A0 (en) | 1999-06-08 | 2002-08-14 | Regeneron Pharma | Modified chimeric polypeptides with improved pharmacokinetic properties |
| US7431989B2 (en) | 2003-05-06 | 2008-10-07 | Tribofilm Research, Inc. | Article with lubricated surface and method |
| WO2005044853A2 (en) | 2003-11-01 | 2005-05-19 | Genentech, Inc. | Anti-vegf antibodies |
| BRPI0908361A2 (pt) * | 2008-02-07 | 2015-04-07 | Amgen Inc | Seringas previamente cheias contendo composição e métodos de preparação das mesmas e de estabilização de agente de ligação específico em composição. |
| HRP20170615T1 (hr) | 2008-06-25 | 2017-07-28 | Esbatech, An Alcon Biomedical Research Unit Llc | Stabilna i topiva protutijela koja inhibiraju vegf |
| BRPI0921469B1 (pt) | 2008-11-03 | 2022-01-18 | Molecular Partners Ag | Proteínas de ligação que inibem a interação com o receptor de vegf-a, composição farmacêutica |
| US9597458B2 (en) * | 2009-10-29 | 2017-03-21 | W. L. Gore & Associates, Inc. | Fluoropolymer barrier materials for containers |
| WO2011117878A1 (en) | 2010-03-20 | 2011-09-29 | Pawan Trilokchand Agrawal | Plastic pre-filled syringe |
| JP5931847B2 (ja) * | 2010-03-31 | 2016-06-08 | オキュジェクト， エルエルシー | 眼内薬剤送達のためのデバイスおよび方法 |
| TWI510246B (zh) | 2010-04-30 | 2015-12-01 | Molecular Partners Ag | 抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質 |
| DE102011009057B4 (de) * | 2011-01-20 | 2015-12-10 | Schott Ag | Plasma-Behandlungsvorrichtung zur Herstellung von Beschichtungen und Verfahren zur innenseitigen Plasmabehandlung von Behältern |
| JP6207401B2 (ja) * | 2012-01-31 | 2017-10-04 | テルモ株式会社 | プレフィルドシリンジ用シリンジ |
| MA42648B1 (fr) * | 2012-06-01 | 2019-10-31 | Novartis Ag | Seringue |
| AU2012101677B4 (en) | 2012-07-03 | 2012-12-20 | Novartis Ag | Device |
| JOP20200175A1 (ar) * | 2012-07-03 | 2017-06-16 | Novartis Ag | حقنة |
| EP2890389A1 (en) * | 2012-08-28 | 2015-07-08 | Novartis AG | Use of a vegf antagonist in treating ocular vascular proliferative diseases |
| DE102013103676A1 (de) * | 2013-04-11 | 2014-10-30 | Schott Ag | Behälter mit geringer Partikelemission und reibkontrollierter Trockengleitoberfläche, sowie Verfahren zu dessen Herstellung |
| RU2676274C2 (ru) * | 2013-07-11 | 2018-12-27 | Новартис Аг | Применение антагониста vegf при лечении хориоретинальных неоваскулярных нарушений и нарушений проницаемости у педиатрических пациентов |
| EP4378504A3 (en) * | 2013-10-07 | 2024-09-04 | Ocuject, LLC | Intraocular delivery devices |
| JP6612763B2 (ja) * | 2014-10-02 | 2019-11-27 | テルモ株式会社 | タンパク質溶液製剤を収容するための医療用容器 |
-
2016
- 2016-11-18 MX MX2018006171A patent/MX2018006171A/es unknown
- 2016-11-18 US US15/776,418 patent/US20180326126A1/en not_active Abandoned
- 2016-11-18 JP JP2018525783A patent/JP2019501687A/ja active Pending
- 2016-11-18 EP EP16801743.2A patent/EP3377151A1/en active Pending
- 2016-11-18 CN CN201680067304.7A patent/CN108290004A/zh active Pending
- 2016-11-18 CA CA3005692A patent/CA3005692A1/en active Pending
- 2016-11-18 AU AU2016356047A patent/AU2016356047B2/en active Active
- 2016-11-18 KR KR1020187016631A patent/KR20180083377A/ko not_active Withdrawn
- 2016-11-18 RU RU2018121813A patent/RU2018121813A/ru unknown
- 2016-11-18 BR BR112018010005A patent/BR112018010005A2/pt not_active IP Right Cessation
- 2016-11-18 WO PCT/EP2016/078136 patent/WO2017085253A1/en not_active Ceased
-
2018
- 2018-05-04 ZA ZA2018/02922A patent/ZA201802922B/en unknown
-
2022
- 2022-07-18 US US17/867,098 patent/US20220362441A1/en not_active Abandoned
- 2022-09-12 JP JP2022144630A patent/JP2022177129A/ja active Pending
-
2025
- 2025-04-03 US US19/169,549 patent/US20250229010A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016356047A1 (en) | 2018-05-24 |
| MX2018006171A (es) | 2018-12-19 |
| EP3377151A1 (en) | 2018-09-26 |
| US20180326126A1 (en) | 2018-11-15 |
| WO2017085253A1 (en) | 2017-05-26 |
| US20220362441A1 (en) | 2022-11-17 |
| CN108290004A (zh) | 2018-07-17 |
| JP2019501687A (ja) | 2019-01-24 |
| AU2016356047B2 (en) | 2021-10-21 |
| JP2022177129A (ja) | 2022-11-30 |
| BR112018010005A2 (pt) | 2018-11-21 |
| KR20180083377A (ko) | 2018-07-20 |
| CA3005692A1 (en) | 2017-05-26 |
| ZA201802922B (en) | 2019-06-26 |
| RU2018121813A3 (ru) | 2020-03-05 |
| US20250229010A1 (en) | 2025-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018121813A (ru) | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf | |
| RU2016148324A (ru) | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf | |
| JP2019501687A5 (ru) | ||
| IL272913B2 (en) | A low volume pre-filled syringe is sterilized | |
| US12434015B2 (en) | Autoinjector | |
| TWI632920B (zh) | 注射器 | |
| JP2014087678A5 (ru) | ||
| EA201391812A1 (ru) | Отдельные вариабельные домены против vegf, слитые с fc-доменами | |
| AU2016383061A1 (en) | Wearable automatic injection device and related methods of assembly and use | |
| BR112015027385A2 (pt) | Anticorpos modificados de ligação ao fcrn humano e métodos de uso | |
| MX2017012506A (es) | Composicion farmaceutica para la prevencion y tratamiento de enfermedades del ojo que contiene, como ingrediente activo, una proteina de fusion en la cual el peptido que penetra el tejido y la preparacion del factor de crecimiento endotelial antivascular se fusionan. | |
| MX2021004994A (es) | Dosificacion subcutanea y administracion de anticuerpos anti-c5 para el tratamiento de la hemoglobinuria paroxistica nocturna (pnh). | |
| TW202026011A (zh) | 含有抗-介白素-４受體（ｉｌ-４ｒ）抗體之安定化配製物 | |
| Erichev et al. | Evaluating the efficacy of anti-VEGF therapy in patients with exudative age-related macular degeneration and concomitant glaucoma | |
| MX2017003667A (es) | Jeringa pre-llenada de aplicacion oftalmica. | |
| HK40030912A (en) | Syringe | |
| Boyce | Sub-retinal haemorrhage: case report | |
| Nuzzi | Bevacizumab/pegaptanib | |
| RU2020128686A (ru) | Анти-pvrig антитела и способы применения |